Andrew Kuykendall, MD, is an investigator on the phase 3 VERIFY trial (NCT05210790), findings from which demonstrate the safety, reliability, and effectiveness of rusfertide to treat polycythemia vera ...

The UK medicines regulator has approved Pfizer’s marstacimab for patients aged 12 years or older with severe haemophilia A or B, offering a new subcutaneous treatment option.

Eli Lilly ( LLY 0.89%) has been growing its sales at a good clip over the past year. This is partly thanks to Zepbound, a ...

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

From Crohn disease to uncomplicated urinary tract infections and beyond, the FDA issued several high-impact drug approvals ...

In February, the FDA approved the Odactra tablet, a sublingual immunotherapy, to treat house dust mite-induced allergic ...

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo ... The Vyvgart Hytrulo ...

The single-dose prefilled subcutaneous injection was developed as part ... William Blair writes the self-administration option will be a strong growth driver for the Vyvgart franchise in both ...

There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...

You are not welcome here." It comes after the Trump administration has moved to deport individuals like Mahmoud Khalil, a 30-year-old Palestinian graduate student at Columbia University ...